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Abstract
Background: In our previous study, endometrium side population cells (SP cells) were isolated from postpartum
murine uterus, and characterized by a heterogeneous population of stem/progenitor cells. In this study, we
investigated the effect of estrogen on the proliferation and differentiation of SP cells.
Methods: SP and non-SP cells of postpartum murine endometrium were isolated by DNA dye Hoechst 33342. The
expression of estrogen receptor 1 (ESR1) was measured by reverse transcription polymerase chain reaction
(RT-PCR), Real-time PCR, Western blot, immunofluorescence and immunohistochemistry. The proliferation and
differentiation of SP cells treated with different concentrations [10(-8) M-10(-6) M] of estradiol (E2) and E2+
ICI182780 (Faslodex, inhibitor of ESR1) were measured by 3-(4, 5-dimethylthiazoly1-2)-2,5-diphenyltetrazolium
bromide(MTT) and clonogenic assays.
Results: (1) SP cells expressed ESR1 at a higher level than non-SP cells. (2) The level of E2 in the serum and the
expression of ESR1 in the uterus of postpartum murine changed in the same manner with the ratio of SP cells to
total uterus cells at a different postpartum time point. ESR1, as ABCG2 is also predominantly located in the stroma
and the glandular epithelium of the uterus. (3) 10(-6) M E2 notably promoted the proliferation of SP cells after
treatment for 24 h. This effect could be inhibited by ICI182780. E2 at the concentration of 10(-7) M or 10(-8) M was
sent to impair the large cloning efficiency (CE) of SP cells.
Conclusions: The effect of estrogen on the proliferation and differentiation of endometrium SP cells via ESR1 was
observed and it was in a concentration dependent fashion. Clearly, more work is needed to understand the in vivo
effect of E2 at the physiological concentration on the differentiation of SP cells.
Background
It has been proposed that human endometrium contain a
population of stem cells which are responsible for their
remarkable regenerative ability [1,2]. Side population
cells (SP cells) have been shown in many adult tissues,
and the phenotypes of SP cells might represent common
molecular features for a wide variety of stem cells [1-3].
In a previous study, SP cells were isolated from the endo-
metrium of postpartum murine uterus and these SP cells
were characterized by a heterogeneous population of
stem/progenitor cells [3]. Estrogen is an important hor-
mone for repairing postpartum uterus endometrium
repairing. Estrogen receptor (ESR) has two isoforms:
ESR1 and ESR2. Although both ESR1 and ESR2 are pre-
sent in the endometrium, ESR1 seems to be the primary
mediator of the estrogenic action in these tissues [4].
Some investigators found that ESR1 amplification and
over-expression is likely to have a growth stimulatory
effect on endometrium-derived cancer cells [5]. It is
important to know how SP cells participate in the repair
of cyclical and postpartum endometrium, and the effect
of estrogen (via ESR1) in this procedure. Meanwhile,
research on the proliferation and differentiation of
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any medium, provided the original work is properly cited.endometrium SP cells, as well as the effect of steroid hor-
mones, will add knowledge to our understanding of
pathophysiology of endometriosis.
The objectives of the present study were: 1) To evaluate
the potential of the in vivo effect of estrogen on the pro-
liferation and differentiation of SP cells during endome-
trium repairing by investigation of the serum estradiol
level and the expression of ESR1 in murine uterus at dif-
ferent postpartum stages. 2) To observe directly the
in vitro effect of estradiol on the proliferation and differ-
entiation of cultured SP cells treated with different con-
centrations of E2 and ICI182780 (inhibitor of ESR1).
Methods
Animals
Female ICR mice [Institute of Cancer Research (ICR)],
aged 6-8 weeks, were used. ICR mice were purchased from
Model Animal Research Center of Nanjing University
(Nanjing, China). Sixty mice were divided into six groups
based on their postpartum day (Day 1, 7, 14, 18, 21, 28) to
detect serum estradiol (E2) level and the expression of
estrogen receptor 1 (ESR1) in postpartum endometrium.
Another 60 ICR mice were used at postpartum Day 18 to
isolate endometrium side population (SP) cells. Animal
studies were conducted according to the protocols
a p p r o v e db yt h eA n i m a lC a r ea n dU s eC o m m i t t e eo f
Nanjing Medical University.
Cell preparation
Endometrium SP cells were isolated and cultured using
pancreatic enzyme, collagenase, as well as mechanical
separation [3]. Cells were suspended at a concentration of
1×1 0
6 cells/ml and were then incubated in 5 μg/ml
Hoechst 33342 dye (Sigma-Aldrich, St. Louis, MO).
Suspensions were analyzed and sorted using a FACS
Vantage SE cell sorter (Becton Dickinson, Franklin Lakes,
NJ) with a 350 nm UV diode laser. Hoechst 33342 fluores-
cence was measured at both 402 - 446 nm for Hoechst
blue and 640 nm for Hoechst red.
Immunocytochemistry
The freshly sorted SP cells were collected and re-sus-
pended to a final concentration of 1 × 10
6/ml. An aliquot
of 0.2 ml of the suspension was used for each cell smear.
Cells were cytospun onto plus-coated slides, air dried,
and fixed in acetone for 10 min at 4°C. The sections were
incubated with anti- ESR1 pAb (1:50 dilution, Santa
Cruz, CA) for 24 hours and then with FITC secondary
antibodies. Nuclear staining was performed with 5 μg/ml
Hoechst 33342. The percentage of positive expression of
ESR1 was calculated by counting positive cells in every
400 cells from three independent experiments.
Five-micrometer-thick coronal sections (paraffin-
embedded) of postpartum mouse uterus were exposed
to citrate buffer (0.01 M, pH 6.0) and heated in a micro-
wave oven for 10 minutes for antigen retrieve. The sec-
tions were treated with 0.3% hydrogen peroxide in
methyl alcohol for 20 minutes and blocked with 10%
normal goat serum (Zhongshan Biotechnology Co. Ltd.,
Beijing, China) for 2 hours. It was allowed to react for
12 hours with the primary rabbit anti-ESR1 antibody
(1:50 dilution, Santa Cruz, CA) or normal rabbit IgG
(1:100 dilution, Santa Cruz, CA) as a negative control.
Sections were then incubated with horseradish peroxi-
dase (HRP)-conjugated goat anti-rabbit secondary anti-
body (1:200 dilution, Santa Cruz Biotechnology Inc, CA)
at room temperature for 1 hour and the reactivity was
visualized with peroxidase-substrate solution (diamino-
benzidine, DAB) until the desired stain intensity devel-
oped. Sections were counterstained with Harris’s
hematoxylin for 35 seconds.
RT-PCR and real-time PCR
Total RNA was extracted from the pellets of sorted SP and
main population (MP, non-SP) cells using a Trizol
Reagent (Invitrogen Corporation, Carlsbad, CA) and was
reverse-transcribed into cDNA with a reverse transcription
kit (Takara Bio Inc., Shiga, Japan) as per manufacturer
instruction. The total RNA and cDNA of postpartum
mouse uterus were prepared as the same way. b-actin was
used as a housekeeping gene. PCR was performed using
the following primers: b-actin primers, 5’-CCG TAA AGA
CCT CTA TGC C-3’ and 5’-CTC AGT AAC AGT CCG
CCT A-3’ for a 278-bp fragment; ESR1 primers, 5’-GCA
CAG GAT GCT AGC CTT GTC TC-3’ and 5’-CCA GCT
TGC AGG TTC ATT GTG-3’ for a 98-bp fragment.
Cycling conditions for both b-actin and ESR1 were 94°C
for 5 minutes, 94°C for 30 seconds, 56°C for 1 minute, and
72°C for 1 minute, 35 cycles. The PCR products were
separated on 2% agarose gels for analysis.
Real-time PCR primers were the same for RT-PCR.
Cycling conditions for b-Actin and ESR1 were 95°C for 10
seconds, 95°C for 5 seconds, 60°C for 31 seconds, 40
cycles. Melting curve analysis was performed to confirm
the real-time qPCR products. Relative abundances of the
target mRNAs were calculated using the 2-
ΔΔCT method
[6].
Western blot
The different postpartum days (Day1, 7, 14, 18, 21, 28) of
mouse uteri were homogenated on ice with lysis buffer (7
mol/L urea, 2 mol/L thiourea, 4% [w/v] 3-[(3-cholamido-
propyl)-dimethylammonio]-1-propane sulfonate (CHAPS),
2% [w/v] dithiothreitol (DTT), 2% [v/v] immobilized pH
gradient [IPG] buffer, pH 3-10) in the presence of 1% (v/v)
protease inhibitors cocktail kit (Pierce Biotechnology,
Rockford, Illinois, USA). After centrifugation at 40000 g at
4°C for 1 hour, protein extracts in the supernatants were
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protein extracts from each sample were loaded and sepa-
rated by 12% sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and the resulting proteins
were then transferred onto a nitrocellulose membrane.
After treatment with blocking solution (5% non-fat milk
powder in Tris-buffered saline [TBS; pH 7.4]) for 2 hours,
the membranes were incubated with rabbit polyclonal
antibodies of ESR1 (1:50, Santa Cruz Biotechnology, Santa
C r u z ,C A ) ,o rb-tubulin (1:5000, Abcam, Cambridge
Science Park, Cambridge, UK) at 4°C overnight. The
membrane was then incubated with HRP-conjugated anti-
rabbit secondary antibodies (1:1000, Zhongshan Biotech-
nology Co. Ltd., Beijing, China) for 1 hour at 37°C, and
examined by enhanced chemiluminescence (Amersham
Biosciences, Uppsala, Sweden). The membranes were then
scanned, and the signal intensity of each band was quanti-
fied using AlphaEaseFC (Fluorchem 5500) software (Alpha
Innotech Corp., CA). Relative protein levels in each sam-
p l ew e r en o r m a l i z e dt ot h eb-tubulin level in order to
standardize the loading variations.
Serum preparation and Hormone assays
Mice of different postpartum time (day1, 7, 14, 18, 21, 28)
were anesthetized by 1% pentobarbital sodium and
approximately 1 ml blood was withdrawn from the right
ventricle. The blood samples were kept at room tempera-
ture for 2 hours, centrifuged at 1500 g for 10 minutes, and
the sera were stored at -80°C until use. Concentrations of
estradiol in the sera and conditioned medium of cultured
SP cells were measured via a sensitive (<0.02 ng/mL) and
reproducible (total coefficient of variation [CV], <10%)
radioimmunoassay (RIA) with a measurement range from
0 . 1t o2 0n g / m L .T h eR I Ak i t sw e r eo b t a i n e df r o mt h e
Beifang Biotechnique Institute (Beijing, China).
Clonogenic assay
SP cells were seeded in triplicate at 500 cells/cm
2 in flat-
bottomed, 6-well culture plates. For the first 2 days, the
culture medium was phenol red-free DMEM/F-12 (Gibco,
USA) containing 5% FBS, 100 IU/ml penicillin, and
10 mg/ml streptomycin. Starting from Day 3, the cells
were treated with different concentrations (10
-8 -1 0
-6M)
of 17bE2 or 17bE2 in the presence of ICI182780 (inhibiter
of ESR1, 10
-6M), Cells were cultured for 15 days in 5%
CO2: 95% air. The culture medium was changed every
2 days. Colonies were monitored microscopically daily to
ensure that they were derived from single cells.
The dishes for clone analysis were fixed in 4% parafor-
maldehyde in PBS for 30 minutes, stained with Harris’s
h e m a t o x y l i nf o r5m i n u t e s ,t h e nw a s h e di nr u n n i n gt a p
water for 20 minutes and dried. Clusters of cells were
considered colonies when they were visible macroscopi-
cally and contained more than 50 cells. Colonies more
than 70 cells were considered large clones. Colonies were
counted and images were recorded. The cloning effi-
ciency (CE) was determined from the formula: CE (%) =
(number of colonies/number of cells seeded) × 100%.
Cell proliferation and viability assays
The reduction of tetrazolium salts is now widely accepted
as a reliable way to examine cell proliferation. The 3-(4,5-
dimethylthiazoly1-2)-2,5-diphenyltetrazolium bromide
(MTT) is reduced by metabolically active cells, in part by
the action of dehydrogenase enzymes, to generate redu-
cing equivalents such as NADH and NADPH. The result-
ing intracellular purple formazan can be solubilized and
quantified by spectrophotometric means. Briefly, SP cells
were plated at a density of 3 × 10
4cells/well in 96-well
plates, cultured for 2 days in phenol red-free serum
medium and then exposed with different concentrations
(10
-8 -1 0
-6M) of 17bE2 in the presence or absence of
ICI182780 (10
-6M) for 24 hours. The cells were then incu-
bated with 0.5 mg/ml MTT for 4 hours at 37°C. The
media was carefully removed and 150 μlo fD M S Ow e r e
added to each well for 15 minutes in order to solubilize
the dark blue formazan crystals formed in intact cells. The
absorbance was measured at 570 nm with the microplate
reader (Bio-Tek ELX800, USA).
Statistics
Each experiment was repeated at least three times. All
data were presented as mean ± SD. One-way analysis of
variance was used to compare the mRNA and protein
levels. Chi-square analysis was used to compare the
rates of SP cell large clones. A value of P < 0.05 was
considered statistically significant.
Results
Variation of SP cells proportions along with postpartum
days
Fluorescence activated cell sorter (FACS) analysis
showed that along with the changing of postpartum
time (Day1, 3, 7, 14, 18, 21, 28, 60) the proportion of SP
cells increased significantly and then gradually decreased
after Day 18 (P < 0.05) (Figure 1A).
Variation trend of serum E2 level along with postpartum
days
Serum estradiol level was high at D1, and then remark-
ably decreased at Day 7 (Figure 1B). The E2 level, on
the other hand, had a gradual increase from Day 7 to
Day 18 after which it showed a decreasing trend (P <
0.05) (Figure 1B). This trend is representative of the
change in SP cell proportion. These findings suggest
that estradiol may play a role in the regulation of SP
cells, which participate in the regeneration of postpar-
tum mice endometrium.
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postpartum days
Analysis with real-time PCR showed increased ESR1
expression within the first 14 days of postpartum, with
t h eh i g h e s tp e a ka tD a y1 4( P<0 . 0 5 )( F i g u r e1 C ) .T h i s
trend was similar to the trend of SP cell ratio in the
endometrium of postpartum mice. Western blot showed
the same result as PCR analysis. Compared with other
days of postpartum, ESR1 obviously expressed at highest
level at Day 14 (P < 0.05) (Figure 1D).
Immunohistochemistry showed the same variation as
Real-time PCR analyses. Luminal epithelium at Day 1
expressed low level of ESR1, whereas stroma and gland-
ular epithelium at Day 7 showed mid level of ESR1
expression. Stroma at Day 14 expressed high level of
ESR1. From Day 18 to Day 28, expression of ESR1
decreased gradually. At Day 18, significant amounts of
ESR1 were expressed in the Glandular epithelium. ESR1
expression was seen to decrease significantly at Day 21
and Day 28 (Figure 2).
Preferential expression of ESR1 in SP cells when
compared with non-SP cells
We also examined the basal expression of ESR1 in SP
cells and non-SP cells. RT-PCR analyses showed that
the expression of ESR1 mRNA was higher in SP cells
than that in non-SP cells (P < 0.05) (Figure 3B, C).
Immunocytochemical analysis showed that 75.18 ±
5.47% of SP cells expressed ESR1, and only 32.28 ± 4.3%
of non-SP cells expressed ESR1 (Figure 3A). These find-
ings suggested that a large number of SP cells were able
to respond to estrogen (target cells of estrogen).
Cell proliferation of SP cells modulated by 17bE2
To study the proliferative effects of 17bE2, SP cells were
treated with different concentrations (10
-8 -1 0
-6M) of
Figure 1 Proportion of SP cells and ESR1expression in postpartum mouse uterus, as well as serum E2 level, in postpartum mice at
different day. Figure 1A. Proportion of SP cells in the uterus of postpartum mice at Day 1 to 60. *Compared with Day 18, P < 0.05. At Day 18,
the proportion of SP cells was highest. Figure 1B. Levels of serum E2 in mice at different postpartum day. #compare to Day 1, P < 0.05; *
compare to Day 18, P < 0.05. Levels of E2 in Day 1 and Day 18 were the highest. Figure 1C. Real-time RT-PCR analyses of ESR1mRNA expression
in postpartum uterus. *compare to Day 14, P < 0.05. Expression of ESR1 mRNA in Day 14 was highest. Figure 1D. Western blot analyses of ESR1
expression in postpartum mouse uterus. ESR1 expression level at day1 was set as a standard as 1. *compare to Day 14, P < 0.05. Level of ESR1
protein in Day 14 was highest.
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-6M).
17bE2 a tt h ed o s eo f1 0
-6 M induced a significant
increase in SP cell numbers (P < 0.05), even though E2
at lower doses (10
-7,1 0
-8 M) could not significantly
change SP cell numbers (P > 0.05) (Figure 4A). The sti-
mulated proliferation was blocked by ICI182780 (P <
0.05) indicating the effect was specifically mediated
through estrogen receptors.
Variation of large CE of SP cells after 17bE2 treatment
T o t a lC Eo fS Pc e l l si na l lo f1 7 bE2 treated groups did
not significantly change. The CEs of large colonies were
as follows: 0.073% ± 0.046% (n = 3) for 10
-6 M1 7 bE2,
0.04% ± 0.031% (n = 3)for 10
-7 M1 7 bE2, 0.027% ±
0.011%(n = 3) for 10
-8 M1 7 bE2., 0.126% ± 0.042 (n = 3)
for 10
-6 M1 7 bE2+ICI182780, 0.073% ± 0.023% (N = 3)
for 10
-7 M1 7 bE2+ICI182780, and 0.113% ± 0.03%
Figure 2 Immunohistochemistry analyses of ESR1 expression in postpartum mouse uterus. Left side was negative control, the middle and
right showed ESR1 expression, which shown at middle (40×) and higher magnification (100×). Scale bar was 20 μm, while right side scale bar
was 10 μm. The arrows indicate ESR1 immunopositive cells.
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-8 M1 7 bE2+ICI182780. There was a sig-
nificant decrease in CE of large colonies of SP cells in
groups treated with 10
-7 Ma n d1 0
-8 Mo f1 7 bE2.
ICI182780 was seen to block this effect (P < 0.05)
(Figure 4C). The size distribution of these SP cells colo-
nies was also examined by scoring 344 colonies from
nine samples and sorting them into numerical order.
Figure 4B shows that colonies could be categorized into
two groups: small colonies (<70 cells) or large colonies
(>70 cells).
Discussion
Adult stem cells have tissue-specific function as they are
known to repair and maintain their corresponding tis-
sues [3]. The concept that endometrial regeneration is
mediated by endometrial stem/progenitor cells was pro-
posed many years ago [7,8]. It is widely believed that
endometrial restoration after menses suggests a need for
estrogen-primed proliferation. In the previous study, it
was shown that SP cells of postpartum murine endome-
trium were a heterogeneous population of endometrial
stem/progenitor cells [3]. In the mouse, the normal
estrus cycle recovers several days after the lactation is
over, which is approximately 21-24 days after parturi-
tion. In this study, an initial increase was seen in the
percentage of SP cells in postpartum murine endome-
trium. This increase was observed until Day 18, after
which a gradual decrease was recorded. It was suggested
that this phenotype might correlate with endocrinologi-
cal hormonal changes after parturition. Uterus is an
important target organ of estrogen. Estrogen receptor
(ER) has two isoforms: ESR1 and ESR2. ESR1 is the
main isoform of ER in humans and rodents. Although
ESR1 and ESR2 were both expressed in endometrium,
when compared with the wild type, it was seen that the
uterus of the ESR1 knockout mice is immature with
Figure 3 Expression of ESR1 in SP and non-SP cells. Figure 3A. Immunocytochemical analyses of ESR1 expression in SP and non-SP cells.
Nuclear Hoechst staining (blue) and immunofluorescent labeling of ESR1 (green) were merged. Scale bar, 100 μm. The arrows indicate ESR1
immunopositive cells (Hoechst and ESR1 staining merged). Figure 3B, C. RT-PCR analyses of ESR1 expression in SP and non-SP cells. 1. SP Actin;
2. Non-SP Actin; 3. SP ESR1; 4. Non-SP ESR1. *P < 0.05.
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E2, there was no thickening of the endometrium or the
muscular layer in ESR1 knockout mice. This is indica-
tive of the primary function of ESR1 in the uterus
[9,10]. Estrogen regulates endometrial cell survival, via-
bility and mitogenic activity via ESR1 [11,12]. Decreased
expression of ESR2 has previously been seen in many
estrogen-dependent tumors [13]. ESR2 acts as a modula-
tor of ESR1 and has an anti-proliferative and pro-apop-
totic role [14]. In this study, it was found that the
expression of ESR1 was greater in SP cells, when com-
pared with the expression in non-SP cells. Since ESR1 is
the dominant isoform in the uterus, it was assumed that
estrogen might regulate SP cells via the ESR1 function
of regenerating the endometrium.
The E2 level in serum and the ESR1 expression in
uterus showed the same trend with the proportion of SP
cells and total uterus cells varying in different postpar-
tum days (Day1 to Day 28). It was found that the E2
level in serum gradually increased from postpartum Day
7, and then declined after Day18. However, the ESR1
expression at both the gene level and the protein level
peaked at postpartum Day 14. It was reported by Kang
et al. [15] that after treatment with 17-ethinyl estradion
(EE) (doses of 3.0 and 10.0 μg/kg/day), ESR1 expression
decreased in the uterine luminal and glandular epithe-
lium, as well as in the stroma and the uterine smooth
muscle cells. The data suggested that the increased
endogenous E2 level could negatively regulate ESR1
expression in uterus to some extent, which could have
Figure 4 Effect of 17b-E2 on the proliferation and formation of large cloning efficiency of SP cells. Percentage and large cloning
efficiency of SP cells treated with 17b-E2 and 17b-E2 +ICI182780 (Faslodex, inhibitor of ESR1) for 24 h. Figure 4A. SP cells were pretreated with
17b-E2 and 17b-E2 +ICI182780 at different concentration (10
-8 to10
-6M) for 24 h, after which the cell viability was estimated by the MTT assay.
n = 4 experiments. * Compared with control, p < 0.05. Figure 4B. Distribution of colony size of SP cells cultured in phenol red-free sera medium
for 15 days. The number of cells per colony from 344 colonies was counted, with the data generated used to discriminate small and large
colonies, as shown by the vertical line at 70 cells. Hematoxylin staining of small clone (left) and large clone (right). Scale bar, 100 μm. Figure 4C.
Large cloning efficiency of SP cells treated with 17b-E2 and 17b-E2 +ICI182780 at different concentration (10
-8 to10
-6M) for 15 days. #Compared
to control, and *P < 0.05.
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ESR1 expression peaks.
In this study, it was found that ESR1 in mouse uterus at
postpartum Day 14 was predominantly expressed in
endometrium stroma, while it was highly expressed in
glandular epithelium at postpartum Day 18. In previous
studies, it was found that the ATP-binding cassette
superfamily G member 2 (ABCG2) was mainly expressed
in postpartum mouse endometrium stroma. ABCG2 was
also expressed in a small part of vascular endothelial cells
and glandular epithelium [3]. ABCG2 is specially
expressed in SP cells. Estrogen promotes endometrium
cell mitosis, which is an important factor for the develop-
ment and functional maintenance of female reproductive
system. In uterus, E2 promotes endothelial progenitor
cell (EPC) differentiation, migration, proliferation, and
apoptosis inhibition [16-18]. The enhanced biological
activities in EPC by E2 are blocked by the specific ESR1
antagonist ICI182780, which indicates that the effect of
estrogen on EPCs is via functional ESR1 in EPCs. In this
study, we found that 10
-6ME 2 could significantly pro-
mote proliferation of SP cells in vitro and this effect
could be blocked by ICI182780 (P < 0.05). Three other
concentrations of E2 at a lower level showed concentra-
tion dependent tendency of stimulation of SP cell prolif-
eration although they did not reach statistical
significance. Therefore, E2 leads to the promotion of SP
cells via ESR1 by participating in the regeneration of the
endometrium.
Stem cells are able to differentiate, self-renew and
replace themselves, into committed progenitors. These
committed progenitors are differentiated transit amplifying
(TA) cells, which rapidly proliferate and finally differenti-
ate to produce a large number of terminally differentiated
functional cells with no capacity for proliferation. It is pos-
sible that the large colonies are initiated by putative stem/
progenitor cells and the small colonies are initiated by
putative TA cells [2]. In this study, it was found that CE of
large clones treated by 10
-7Ma n d1 0
-8ME 2 notably
decreased and this effect could be blocked by ICI182780
(P < 0.05). With E2 concentration gradually decreasing
from 10
-6Mt o1 0
-8M, CE of large clones also showed
decreasing trend even though there was not a statistically
significant difference recorded (P > 0.05). These results
indicated that E2 at the circumambient concentration of
physiological range could promote the committed differ-
entiation of SP cells in vitro. The physiological serum con-
centration of 17bE2 in postpartum mice is about 10
-8 M.
Deasy et al., [17] when studying Duchenne Muscular Dys-
trophy (DMD), found that the female muscle-derived stem
cells (MDSCs) regenerated skeletal muscle more efficiently
than those of the males. It was therefore concluded that E2
at high concentrations promoted proliferation of SP
cells of postpartum mouse endometrial, whereas E2 at
physiological concentrations could promote differentiation
of SP cells.
In clinical practice, many patients become infertile due
to declining endometrial regeneration capability. The com-
mon reasons include abortion, infection and endocrinal
dysfunction. Conversely, abnormal endometrial hyperpla-
sia could lead to endometriosis, functional uterine bleed-
ing and endometrial carcinoma [19-22]. The current study
advanced the understanding of the role of SP cells in
repairing postpartum endometrium and in the pathologi-
cal mechanism of abnormal endometrial proliferation, as
well as the accumulated materials for experimental and
clinical applications of endometrial SP cells.
Conclusions
In conclusion, evidence provided in the present study
indicated that E2 promoted SP cells via ESR1, which in
turn plays a role in the regeneration of the endome-
trium. It was observed that E2 at high concentrations
promoted proliferation of SP cells of postpartum mouse
endometrial, while E2 at physiological concentrations
could lead to the promotion of differentiation of SP
cells. Further studies will be required to elucidate the
role of SP cells in repairing postpartum endometrium
and in the pathological mechanism of abnormal endo-
metrial proliferation.
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